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Williams–Beuren syndrome (WBS) is generally the consequence of an interstitial microdeletion at 7q11.23, which
includes the elastin gene, thus causing hemizygosity at the elastin gene locus. The origin of the deletion has been
reported by many authors to be maternal in ∼60% and paternal in 40% of cases. Segregation analysis of
grandparental markers flanking the microdeletion region in WBS patients and their parents indicated that in the
majority of cases a recombination between grandmaternal and grandpaternal chromosomes 7 at the site of the
deletion had occurred during meiosis in the parent from whom the deleted chromosome stemmed. Thus, the
majority of deletions were considered a consequence of unequal crossing-over between homologous
chromosomes 7 (interchromosomal rearrangement) while in the remaining cases an intrachromosomal
recombination (between the chromatids of one chromosome 7) may have occurred. These results suggest that
the majority of interstitial deletions of the elastin gene region occur during meiosis, due to unbalanced
recombination while a minority could occur before or during meiosis probably due to intrachromosomal
rearrangements. The recurrence risk of the interchromosomal rearrangements for sibs of a proband with
non-affected parents must be negligible, which fits well with the observation of sporadic occurrence of almost
all cases of WBS.
INTRODUCTION
The Williams–Beuren syndrome (WBS) is characterised by growth
and mental retardation with a friendly, outgoing personality,
dysmorphic facial features, hypercalcaemia in early infancy, and
congenital cardiovascular malformations, in particular supravalvular
aortic stenosis (1–3). This, almost always sporadically occurring,
disorder (incidence about 1/20 000 newborns) has been shown to
result from a contiguous gene deletion syndrome comprising the
elastin gene (4) and the recently located gene LIM-kinase 1 (5).
Individuals with classic WBS have a chromosomal deletion >500 kb
at 7q11.23 (5). Hemizygosity of the elastin gene is probably
responsible for some of the characteristic features of the WBS,
including supravalvular aortic stenosis, hoarse voice, and some of
the WBS facial features. However, mental retardation and hypercal-
caemia in WBS may indicate that hemizygosity of other genes
adjacent to the elastin locus may also contribute to the phenotype.
The human elastin gene has been mapped to 7q11.23 (6). Indik
et al. (7–8) found a remarkable abundance of Alu repetitive
sequences in the 3′ region of the gene and several alternatively
spliced isoforms.
Repetitive DNA sequences and Alu sequences flanking dele-
tion breakpoints have been noted in a considerable number of
human gene mutations which cause genetic disorders, including
defects in the genes for α-globin (9), β-globin (10), growth
hormone (11) and many others. Such repeated and highly
homologous sequences may facilitate a misalignment of chromo-
somes followed by an unequal crossing-over event which
increases the homologous recombination and greatly enhances
the possibility of a deletion. Mispairing between the repeats might
result in the formation of a loop between the two repeats.
Subsequent excision of the loop will remove the sequences
between the two repeats. One might hypothesize that an unequal
recombination involving Alu sequences at 7q11 would generate
a deletion resulting in WBS. The particular mechanism(s)
involved in rearrangements of proximal 7q remains to be
elucidated by molecular analysis of breakpoint sites.
In order to analyse the mechanisms underlying maternal and
paternal de novo deletions in WBS, we performed a molecular
study of 15 families. The parental origin of the deletion was first
determined. Segregation analysis of 7q11–q21 markers in the 15
families with the available grandparents suggested that the
deletions were in the majority due to an unequal interchromoso-
mal rearrangement.
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Table 1. Results of molecular markers studies around the elastin locus in 15 WBS families
Family Origin of Microsatellites
deletion ELN MvaI ELN dinuc. D7S489 D7S1870
5 mat b,ab,ab b,bc,ab a,bb,aa b,ac,bb
9 mat c,bc,ac a,ab,ab a,bb,aa b,aa,ab
35 mat a,ab,ab c,ab,cc c,ab,bc
70 mat a,bc,ab b,ab,bb
81 mat a,bc,ac b,ab,ab a,bb,ac c,ab,cd
82 mat c,ab,bc b,ab,bb a,bd,ac
84 mat c,ac,bc a,bb,ab a,bb,ac
101 mat a,ac,aa b,ac,bc b,aa,– b,ac,ab
3 pat a,ab,cc c,cc,ab a,ab,bc
34 pat b,ab,ac c,bc,ac c,cc,ab
38 pat a,ab,ab a,ab,bb a,ab,ab
41 pat b,ab,bb a,ab,bb a,ab,ab
52 pat a,aa,cc c,ac,bb b,ab,bb
63 pat c,ac,ab a,ac,bc a,aa,aa
76 pat a,ab,aa b,bb,ab b,bc,ab b,bc,ad
The alleles are given in the order: patient, mother, father. Markers informative for the parental origin of the deletion are shown in bold. Pat, paternal deletion; mat,
maternal deletion. Families 3, 5, 9, 34, 35, 38, 41, 52, 63, 70 and 76 were also reported by Robinson et al. (30).
Figure 1. (A) Haplotype representation of chromosome 7 markers for WBS families with maternal (M) or paternal (P) deletion at the elastin gene. (B) Control families
with normal (N) elastin gene. Alleles inherited from the grandmother are shown by hatched rectangles, markers inherited from the grandfather are shown by black
rectangles. Closed circles represent uninformative markers.
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Figure 2. Results for the microsatellite loci D7S672, D7S669 and D7S504 in
Family 5 (A) and Family 82 (B). The patient in Family 5 has inherited the
grandpaternal allele c for D7S672 and the grandmaternal allele c for D7S669,
indicating crossing-over between markers flanking the deletion region. The
patient of Family 82 has inherited the grandmaternal alleles b and d for the loci
D7S672 and D7S669, excluding crossing over, the grandpaternal allele d for
D7S504. Lane 1, mother; lane 2, patient; lane 3, father; lane 4, maternal
grandmother; lane 5, maternal grandfather.
RESULTS
The 15 WBS patients were genotyped for the elastin gene or for
sequences flanking this gene. The absence of maternal or paternal
contribution to the patients in at least one of these loci,
demonstrated the origin of the deletion (Table 1). In eight cases
there was no maternal inheritance of these markers, and in the other
seven cases, there was lack of paternal alleles.
Fluorescent in situ hybridization (FISH) analysis of the parents,
with the probe WSCR (ONCOR), demonstrated that all the
deletions had occured de novo.
The 15 families consisting of the patient, the two parents and the
available maternal or paternal grandparents were genotyped using
microsatellites centromeric and telomeric adjacent to the elastin
gene. The markers allowed us to determine which allele was
inherited from the parents and from the grandparents. Haplotype
analysis of the flanking markers on each side of the deletion
showed a recombination event between the centromeric (D7S663,
D7S645, D7S672, D7S653) and the telomeric loci (D7S669,
D7S440, D7S634, D7S524, D7S630) in 10 out of the 15 analysed
families (Fig. 1A). As shown in Figure 2A, in Family 5 the WBS
patient inherited the allele ‘c’ from the maternal grandfather for
locus D7S672. The allele ‘c’ for locus D7S669 was inherited from
the maternal grandmother, suggesting a crossing-over between the
two reported loci, which caused the deletion at the elastin gene. In
contrast, in Family 82 (Fig. 2B) the alleles ‘b’ (at D7S672) and ‘d’
(at D7S669) were inherited from the maternal grandmother. A
recombination event between the grandmaternal and grandpaternal
haplotypes in the deleted region is unlikely.
Buetow et al. (12) showed that the elastin gene maps between
D7S502 and D7S524. Biallelic inheritance was observed with the
markers D7S663, D7S645, D7S672, D7S669, D7S440, D7S634
and D7S524 (Table 2), thus excluding hemizygosity at these loci
for most of the WBS patients.
These results indicate that unequal crossing-over between the
two chromosomes 7 is the mechanism causing the interstitial
deletions in the majority of cases of WBS with elastin deletions.
No recombination of markers around 7q11.23 could be
detected in the control families, who had no deletion of the elastin
gene (Table 3 and Fig. 1B).
Since the 7q31–32 and 7p13 regions are frequently involved in
rearrangements (12), we also investigated the recombination
events occurring at the two telomeric ends. In seven WBS
families we detected a second recombination event (Table 2,
Families 5, 9, 35, 70, 101, 3 and 38) with the markers D7S504,
D7S550 and D7S559 mapping between 7q31 and 7qter. One
family (84) did not show recombination for D7S559 and two
families (41 and 63) were not informative. The results of analysis
of the microsatellites D7S507, D7S513, D7S481 and D7S531
close to the 7pter region demonstrated an additional recombina-
tion in the short arm in Families 70, 84, 41 and 63. The five
families (81, 82, 34, 52 and 76) with no evident crossing-over at
the deleted region, showed recombination either at 7pter (Fam-
ilies 81 and 34) or 7qter (Families 81, 82, 52 and 76). Family 82
had a recombination starting at D7S504 (Fig. 2B) for the 7q.
Family 52 showed two recombinations, the first between D7S479
and D7S504, the second at D7S559 (Fig. 1A). The same markers
were used for the control families; eight showed recombination
either at 7qter or at 7pter (Families C2, C6, C7, C8, C9, C10, C11
and C12). Families C1, C3 and C5 had a crossing-over between
D7S524 and D7S479. The results for control families, indicate
that the telomeric regions are more recombinogenic than the loci
close to the elastin gene.
DISCUSSION
We have demonstrated that in 10 out of the 15 (67%) WBS families
with a de novo deletion within 7q11.23, the segment flanking the
deleted region contained recombined haplotypes. Therefore the
deletion must be the result of an unequal crossing-over event
between the chromosome 7 homologues during gametogenesis. An
excess of meiotic recombination at 7q11.23 and at 7pter or 7qter,
might partially explain the resulting deletion. The remaining five
(33%) families showed no recombination at either side of the
deletion. The genetic distance between D7S653 and D7S669 is 8
cM, and thus the probability of a double recombination is very low.
It is possible that the deletions in the non-recombined families result
from intrachromosomal rearrangements. Thus, elastin deletions
causing the WBS might arise either by interchromosomal events
(unequal crossing-over) or by intrachromosomal rearrangements.
No sex specific occurrence of intra- or interchromosomal rearrange-
ments was demonstrated (2/8 for maternal WBS, 3/7 for paternal
WBS). This is in contrast with the preponderance of unequal
crossing-over in males and the preponderance of intrachromosomal
deletion occurring in females as proposed by Leguern et al. (14) for
hereditary neuropathy with liability to pressure palsies (HNPP).
Meiosis is the basis for the production of haploid gametes from
diploid cells, allowing sexual reproduction in eukaryotic organ-
isms. Meiotic cells undergo DNA replication followed by the
establishment of physical connections between homologous
chromosomes. Paired chromosomes undergo genetic recombina-
tion followed by reductional division at meiosis I. The mechan-
ism of meiotic recombination includes reciprocal breakage,
exchange of DNA segments and rejoining of chromatids.
On the basis of observed recombination frequencies, meiotic
recombination does not occur randomly along chromosomes, but
seems to be more or less frequent in specific regions. The
structure of chromatin is directly involved in recombination as
demonstrated by lack of crossing-over in highly condensed
heterochromatin (15). Unequal recombinations are mediated by
related gene sequences or repetitive sequence elements, as
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Table 2. Microsatellite analysis of chromosome 7 markers in 15 WBS families
The order of the family members available for genotype analysis is always indicated under the family number. Allele designations (marked a–f) are arbitrary. P,
patient; M, mother; F, father; GM, grandmother; GF, grandfather. Bold indicates allele inherited from the grandmother. Bold italic indicates allele inherited from
the grandfather. Underline indicates biallelic inheritance for markers flanking the elastin gene.
proposed by the presence of repetitive DNA sequences and Alu
sequences flanking deletion breakpoints in many human genetic
disorders (9–11). Misaligned non-sister chromatids during mei-
osis and misaligned sister chromatids, followed by excision of a
chromatid loop, have also been proposed as a mechanism for
deletions of several Mb such as those in the Prader–Willi/Angel-
man syndrome (16) and HNPP (14). The most abundant
repetitive elements in the human genome are the Alu repeats, they
have also been shown to be involved in a considerable number of
human gene deletions (17–25).
The human elastin gene has relatively large introns which are
characterized by Alu repetitive elements clustered at the 3′ end
(7). The presence of repetitive elements might facilitate chromo-
some 7 misalignment in the elastin gene region. Furthermore, the
breakpoints in the LIM-kinase1 gene, which is adjacent to elastin
and directly involved in the partial WBS phenotype, seem to
occur within Alu repeats (5). This finding strengthens the
argument that Alu sequences are involved in unequal recombina-
tion leading to WBS deletion. Additional work is required to
characterize the precise sequence at the deletion breakpoints of
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Table 3. Microsatellite analysis of chromosome 7 markers in 12 control families
The order of the family members for genotype analysis is always child, mother, father, grandmother, grandfather. Families C1–C5, pater-
nal grandparents; C6–C12, maternal grandparents. Allele designations (marked a–f) are arbitrary. Bold indicates allele inherited from
the grandmother. Bold italic indicates allele inherited from the grandfather.
classical WBS (>500 kb), in order to determine the pathogenetic
mechanism(s) that cause these (and other) deletions.
Unequal crossing-over during meiosis was also suggested as a
mechanism generating DNA duplication on chromosome 17
causing Charcot–Marie–Tooth disease, and the deletion in the
same region causing HNPP (26). Duplications and deletions have
been also described in the LDL receptor gene (17). For the elastin
gene or the 7q11.2 region there is no description of patients with
a duplication. In addition to the difficulty in detecting such a
duplication with an unknown phenotype, it is possible that the
corresponding duplication is either not associated with an
abnormal phenotype or that it is lethal.
In the control families, recombinations had mainly occurred at
the two chromosome 7 telomeres and not at the elastin locus.
Genotyping of these few control families seems to suggest that the
chromosome segment 7q11 is not especially prone to recombina-
tion. It may be expected that a lower recombination frequency
occurs in regions where an intact structure of both alleles must be
maintained for correct gene expression.
A practical consequence of our findings is that they can
improve prediction of recurrence risk for sibs of an affected
proband. If a recombination around the deleted segment can be
demonstrated, the deletion must have occurred during meiosis;
mitotic recombination is extremely unlikely, and thus the
recurrence risk will be virtually zero. In case of a presumed
intrachromosomal recombination, an unlikely premeiotic origin
cannot be fully excluded. Thus, the possibility of gonadal
mosaicism for the deletion has to be considered, with the
recurrence risk possibly being in the range of 1–2%. Occurrence
of WBS in sibs of unaffected parents has been reported earlier
(27), but to the best of our knowledge has never been reported in
cases with proven elastin deletion. On the other hand, there is one
report of a 22q11.22 microdeletion in sibs of non-deleted parents
(28). It would be interesting to investigate this family for
recombinations around the deletion.
Prader–Willi/Angelman syndrome and CATCH22, like WBS,
are genetic diseases characterized by interstitial deletions close to
the centromere. Segregation analysis using markers flanking the
microdeletion region in these three conditions might provide
further information as to whether a common mechanism is
responsible for interstitial deletions.
MATERIALS AND METHODS
The patients were selected from a series of WBS patients
investigated with microsatellite markers and FISH at the Institute
of Medical Genetics of the University of Zürich; clinical and
molecular data have been reported by Kotzot et al. (29) and
Robinson et al. (30).
DNA was extracted from peripheral blood of the probands with
WBS, from each parent, and from the grandparents from the side
of the deletion origin, using standard methods.
The following microsatellites with the indication of genetic order
and distance (cM) were used: 7pter–D7S531-(11)-D7S481-(11)-
D7S513-(8)-D7S507-(51)-D7S499-(3)-D7S663-(3)-D7S645-(3)-D
7S672-(1)-D7S653-(1.8)-ELN-(6)-D7S669-(2.4)-D7S440-(0.6)-D7
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S634-(6)-D7S524-(2)-D7S630-(3)-D7S492-(9)-D7S479-(26)-D7S5
04-(51)-D7S550-(4)-D7S559–7qter (31).
The following markers were used in order to determine the
origin of the deletion: (i) ELN MvaI, the amplified products of
exon 20 of the elastin gene were digested with MvaI as described
(32); (ii) ELN dinuc., which maps near exon 18 within the elastin
gene (33); (iii) D7S1870 and D7S489 with an informativity of
85% for detecting deletions at 7q11.23 (34). All primers were
obtained from Research Genetics, with the exception of ELN
MvaI, which was synthesized elsewhere.
Between 200 and 500 ng of DNA were amplified with the
indicated primers for chromosome 7 in a volume of 25 µl. PCR
amplification was performed on a Perkin-Elmer 9600 with 32
cycles of 30 s at 94C, 45 s at 55–60C for the annealing, and 80 s
at 72C for the extension. The reaction product was mixed in an
equal volume of urea loading buffer (42% urea, 0.1% xylene
cyanol, 0.1% bromphenol blue, and 0.1% 0.5 M EDTA) and was
loaded onto a 0.4 mm thick 6% polyacrylamide/50% urea gel.
Visualization of bands was done by silver staining of the gels.
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